Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.

Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision: v3.4.3 replaces Revision: v3.4.2 in the page history.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedAdded a new revision entry (v3.4.2) to the record history. Removed the older government-funding notice and revision v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the new revision tag v3.4.1. Removed the previous revision tag v3.4.0.SummaryDifference0.4%

- Check55 days agoChange DetectedAdded a glossary toggle and color-coded indicators (green for additions, red for deletions) in the study history display, with notes about revision v3.4.0 and No FEAR Act data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check69 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 in the site footer, indicating a minor maintenance update that does not affect trial data or page content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.